Today is day 61 from the final patient enrollment. From the June 3rd PR announcing final patient enrollment.
"Complete trial enrollment comprised 120 dosed patients recruited across multiple sites. Final data collection for the last patient enrolled in the study is expected to occur in early August (Study Day 60), which will then be followed by the process of unblinding study data and the reporting of topline study results."
Here is my question: let’s pretend B works very well in all hospitalized patients. The data shows phenomenal results. No one died, the time to recovery is cut in half, no long term side effects from Covid, etc…..
How do we know it wasn’t because of COMBO with SOC? We will not know if B can be used alone at this point…correct?
Next will be EAU with SOC? Or do we need a full phase 3 on our own?